News & Updates

Type 2 diabetes leads to poorer outcomes in diffuse large B-cell lymphoma

14 Mar 2020

The presence of type 2 diabetes mellitus worsens survival in patients with diffuse large B-cell lymphoma, a recent study has found.

Type 2 diabetes leads to poorer outcomes in diffuse large B-cell lymphoma

14 Mar 2020

Women with high BMI at increased risk of colorectal cancer

14 Mar 2020

A higher body mass index (BMI) is associated with an increased risk of colorectal cancer (CRC) in women, a study has shown. Moreover, the relation between BMI and microsatellite instability (MSI)-high CRC appears to be more robust than that between BMI and microsatellite-stable CRC, but validation in an independent cohort is warranted.

Women with high BMI at increased risk of colorectal cancer

14 Mar 2020

Poor social support lowers rate of chemotherapy toxicity detection in elderly cancer patients

14 Mar 2020

Older cancer patients with poor social support (SS) were less likely to have documented grade 3–5 nonhaematological chemotherapy-related toxicities, a recent study has found.

Poor social support lowers rate of chemotherapy toxicity detection in elderly cancer patients

14 Mar 2020

Patients see, patients do: CRC screening uptake better when physicians themselves get tested

14 Mar 2020

A physician’s screening practices may affect their patients’, with the latter more likely to undergo colorectal cancer (CRC) screening if their physician has been tested, a new study has found.

Patients see, patients do: CRC screening uptake better when physicians themselves get tested

14 Mar 2020

Sipuleucel-T improves survival in mCRPC in real world

14 Mar 2020 by

The use of sipuleucel-T significantly prolongs overall survival (OS) in men with metastatic castration-resistant prostate cancer (mCRPC), regardless of treatment setting, based on real-world data presented at ASCO GU 2020.

Sipuleucel-T improves survival in mCRPC in real world

14 Mar 2020

Algorithm-based smartphone apps not reliable in detecting skin cancer

13 Mar 2020 by

Current algorithm-based smartphone apps show poor and variable performance in detecting all cases of melanoma or other skin cancer, a systematic review of diagnostic accuracy studies has found. Moreover, the existing assessment processes for awarding the Conformit Europenne (CE) marking for these apps are inadequate for protecting the public.

Algorithm-based smartphone apps not reliable in detecting skin cancer

13 Mar 2020

Cognitive impairment ups risk of severe chemotherapy toxicities in elderly cancer patients

13 Mar 2020

Cognitive impairment in elderly cancer patients appear to increase the risk of severe toxicities related to chemotherapy, reports a recent study.

Cognitive impairment ups risk of severe chemotherapy toxicities in elderly cancer patients

13 Mar 2020

Earlier ALT normalization during antiviral treatment tied to reduced HCC risk in CHB

12 Mar 2020

Earlier normalization of serum alanine aminotransferase (ALT) levels in patients with chronic hepatitis B (CHB) who initiated treatment with entecavir or tenofovir correlates with a proportionally lower risk of hepatocellular carcinoma (HCC), regardless of fatty liver or cirrhosis at baseline and on-treatment virological response (VR), according to a recent study.

Earlier ALT normalization during antiviral treatment tied to reduced HCC risk in CHB

12 Mar 2020

Lower GI bleeds: a CRC marker or a consequence of OAC use?

12 Mar 2020 by

Bleeding in the lower gastrointestinal (GI) tract conferred a high risk of colorectal cancer (CRC) in patients receiving oral anticoagulation (OAC) therapy for atrial fibrillation (AF), a retrospective study has shown, underlining the potential of lower GI bleeding as a marker of CRC.

Lower GI bleeds: a CRC marker or a consequence of OAC use?

12 Mar 2020

Mass spectrometry better than routine for residual amyloidosis surveillance

12 Mar 2020

Mass spectrometry outperforms standard surveillance techniques in detecting residual disease in immunoglobulin light-chain (AL) amyloidosis, a recent study has found.

Mass spectrometry better than routine for residual amyloidosis surveillance

12 Mar 2020

News & Updates

Filter by Specialty:

Specialty:

Type 2 diabetes leads to poorer outcomes in diffuse large B-cell lymphoma

Type 2 diabetes leads to poorer outcomes in diffuse large B-cell lymphoma

Women with high BMI at increased risk of colorectal cancer

Women with high BMI at increased risk of colorectal cancer

Poor social support lowers rate of chemotherapy toxicity detection in elderly cancer patients

Poor social support lowers rate of chemotherapy toxicity detection in elderly cancer patients

Patients see, patients do: CRC screening uptake better when physicians themselves get tested

Patients see, patients do: CRC screening uptake better when physicians themselves get tested

Sipuleucel-T improves survival in mCRPC in real world

Sipuleucel-T improves survival in mCRPC in real world

Algorithm-based smartphone apps not reliable in detecting skin cancer

Algorithm-based smartphone apps not reliable in detecting skin cancer

Cognitive impairment ups risk of severe chemotherapy toxicities in elderly cancer patients

Cognitive impairment ups risk of severe chemotherapy toxicities in elderly cancer patients

Earlier ALT normalization during antiviral treatment tied to reduced HCC risk in CHB

Earlier ALT normalization during antiviral treatment tied to reduced HCC risk in CHB

Lower GI bleeds: a CRC marker or a consequence of OAC use?

Lower GI bleeds: a CRC marker or a consequence of OAC use?

Mass spectrometry better than routine for residual amyloidosis surveillance

Mass spectrometry better than routine for residual amyloidosis surveillance